RRRobert C. Rickert

Robert C. Rickert

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert C. Rickert has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Ashima Shukla

    Department of Cell and Developmental Biology, Northwestern University, Chicago, IL, USA

    1 shared publication
  • Carl F. Ware

    Infectious and Inflammatory Diseases Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States of America

    1 shared publication
  • Charlotte R. Leung

    ¶Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA

    1 shared publication
  • Charlotte R. Leung

    Tumor Microenvironment and Cancer Immunology Program, National Cancer Institute designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 1

    1 shared publication
  • Cindi Chen

    Francis I. Proctor Foundation, University of California San Francisco, CA

    1 shared publication
  • Daniel Balsells

    Tumor Microenvironment and Cancer Immunology Program, National Cancer Institute designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 1

    1 shared publication

Latest Publications

  • Open Access

    Regnase-1 is essential for B cell homeostasis to prevent immunopathology

    by Numana Bhat, Richard Virgen-Slane, Parham Ramezani-Rad, Charlotte R. Leung, Cindi Chen, Daniel Balsells, Ashima Shukla, Elaine Kao, John R. Apgar, Mingui Fu, et al.

    Regnase-1 is an emerging regulator of immune responses with essential roles in the posttranscriptional control of immune cell activation. Regnase-1 is expressed in B cells; however, its B cell–specific functions remain unknown. Here, we demonstrate that Regnase-1 prevents severe autoimmune pathology and show its essential role in maintaining B cell homeostasis. Using Cre driver mice for ablation of Regnase-1 at various stages of B cell development, we demonstrate that loss of Regnase-1 leads to aberrant B cell activation and differentiation, resulting in systemic autoimmunity and early morbidity. The basis of these findings was informed by gene expression data revealing a regulatory role for Regnase-1 in the suppression of a transcriptional program that promotes B cell activation, survival, and differentiation. Overall, our study shows that Regnase-1 exerts critical control of B cell activation, which is required for prevention of immunopathology.


  • Open Access

    Loss of the FOXP1 Transcription Factor Leads to Deregulation of B Lymphocyte Development and Function at Multiple Stages

    by Joseph D. Dekker, Gisele V. Baracho, Zilu Zhu, Gregory C. Ippolito, Robert J. Schmitz, Robert C. Rickert, Haley O Tucker

    The FOXP1 transcription factor is expressed throughout B cell development until its extinction just prior to terminal differentiation. Foxp1 nulls die of cardiac defects at midgestation, but adult rescue via fetal liver transfer led to a strong pre–B cell block. To circumvent these limitations and to investigate FOXP1 function at later stages of B cell differentiation, we generated and analyzed floxed (F) Foxp1 alleles deleted at pro–B, transitional (T) 1, and mature B cell stages. Mb-1cre–mediated deletion of Foxp1F/F confirmed its requirement for pro–B to pre–B transition. Cd21- and Cd19cre deletion led to significant reduction of germinal center formation and a second block in differentiation at the T2/marginal zone precursor stage. T-dependent and -independent immunization of FOXP1 mutants led to reduction of Ag-specific IgM, whereas responses of class-switched Abs were unimpaired. Yet, unexpectedly, plasmablast and plasma cell numbers were significantly increased by in vitro BCR stimulation of Foxp1F/F splenic follicular B cells but rapidly lost, as they were highly prone to apoptosis. RNA sequencing, gene set enrichment analysis, and chromatin immunoprecipitation sequencing analyses revealed strong enrichment for signatures related to downregulation of immune responses, apoptosis, and germinal center biology, including direct activation of Bcl6 and downregulation of Aicda/AID, the primary effector of somatic hypermutation, and class-switch recombination. These observations support a role for FOXP1 as a direct transcriptional regulator at key steps underlying B cell development in the mouse.


  • Open Access

    New Methods To Analyze B Cell Immune Responses to Thymus-Dependent Antigen Sheep Red Blood Cells

    by Ellen J. McAllister, John R. Apgar, Charlotte R. Leung, Robert C. Rickert, Julia Jellusova

    B cells contribute critically to an effective immune response by producing Ag-specific Abs. During the immune response to so-called “thymus-dependent Ags,” activated B cells seek T cell help and form germinal centers. In contrast, thymus-independent Ags generally do not induce germinal center formation. In the germinal center, B cells undergo somatic hypermutation, affinity-based clonal expansion, and differentiation to produce plasma cells and memory B cells. Valuable insight into these processes has been gained by using model hapten–carrier complexes or SRBCs. SRBCs induce robust germinal center formation in mice. Therefore, this Ag is commonly used to study germinal center responses. In contrast to haptenated Ags, thus far it has been difficult to measure the titer of Ag-specific Abs or the expansion of Ag-specific B cells after immunization with SRBCs. We have developed new, simple methods to access these parameters, thus providing new tools to study germinal center and Ab responses.